Condition: ATTR Amyloidosis Wild Type · ATTR Gene Mutation · Carpal Tunnel Syndrome · Sponsor: Helse Møre og Romsdal HF
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
This description comes directly from the study's public registry record.
Torstein Hole, Professor, MD, PhD · +4770105000, +4793421002 · torstein.hole@helse-mr.no
Jørn A Lillebø, consultant cardiology, MD · +4770105000 · jorn.asle.lillebo@helse-mr.no
Always discuss trial participation with your own doctor first.
| Ålesund Hospital | Ålesund, Møre og Romsdal, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06458374